Economic evaluation of a new blood pressure target for hypertensive patients in Taiwan

Hypertens Res. 2023 Mar;46(3):784-786. doi: 10.1038/s41440-022-01125-6. Epub 2023 Jan 5.

Authors

Shintaro Minegishi¹, Akira Nishiyama²

Affiliations

¹ Department of Medical Science and Cardio-Renal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
² Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan. nishiyama.akira@kagawa-u.ac.jp.

PMID: 36604476
DOI: 10.1038/s41440-022-01125-6

No abstract available

Keywords: CVD (cardiovascular disease); Cost-effectiveness; Guideline; Intensive blood pressure control; Simulation.

Publication types

Editorial
Comment

MeSH terms

Blood Pressure
Cardiology*
Cardiovascular Diseases*
Cost-Benefit Analysis
Humans
Hypertension* / physiopathology
Taiwan